Mucoactive bronchiectasis treatments show no benefit in preventing lung flare-ups

Queen’s University Belfast-led research reports on a multicenter trial finding no significant reduction in pulmonary exacerbations with hypertonic saline or carbocisteine over 52 weeks among adults with non–cystic fibrosis bronchiectasis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup